CEO and Founder of Michelson Diagnostics Ltd, the World's leading manufacturer of Optical Coherence Tomography (OCT) 'VivoSight' skin imaging scanners, which reveal sub-surface skin structure and blood vessels, in-vivo and in real time. 

Mr Holmes has Masters in Physics & Theoretical Physics from University of Cambridge, UK, and is a Fellow of the Institute of Physics and ASLMS

He is author of 8 patents and 24 publications in clinical and scientific journals

At IMCAS, Mr Holmes is particularly interested in meeting with clinicians and company representatives who see potential in OCT image-guided laser treatments for improving efficacy, safety and efficiency.